Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide/poly(I:C) complexes efficiently activate T cells-Reference-Cited by-同舟云学术

Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide/poly(I:C) complexes efficiently activate T cells

Published:2010-01 Issue:1 Volume:19 Page:19-28
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:

Author:

Haenssle Holger A.,Riedl Petra,Buhl Timo,Schardt Anke,Rosenberger Albert,SchÃ¶n Michael P.,Schirmbeck Reinhold

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0625.2009.00954.x/fullpdf

Reference47 articles.

1. Dendritic cells and the control of immunity;Banchereau;Nature,1998

2. Dendritic cell regulation of TH1âTH2 development;Moser;Nat Immunol,2000

3. The first 1000 dendritic cell vaccinees;Ridgway;Cancer Invest,2003

4. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG;Schadendorf;Ann Oncol,2006

5. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity;Balkow;Exp Dermatol,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel nucleotide-packaging vaccine delivers antigen and poly(I:C) to dendritic cells and generate a potent antibody response in vivo;Vaccine;2024-04

2. Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency;Pharmaceutics;2023-01-14

3. Therapeutic Potential of CPPs;CPP, Cell-Penetrating Peptides;2023

4. In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of Twenty-First Century: Exploitation of Peptides as Carriers for Their Intracellular Delivery;RNA Technologies;2022

5. Formulation and Delivery Technologies for mRNA Vaccines;Current Topics in Microbiology and Immunology;2020